Segmental Vitiligo with Confetti-Like Peripheral Depigmentation

    December 2018 in “ European Journal of Pediatric Dermatology/PD. European journal of pediatric dermatology ”
    L. Garofalo
    TLDR Segmental vitiligo affects hair follicle melanocytes, causing small, uniform depigmented spots.
    The document discussed a case of segmental vitiligo characterized by confetti-like peripheral depigmentation, where the depigmented spots were uniformly 1-2 mm in diameter and appeared to follow a follicular pattern. This pattern, along with the presence of inflammatory infiltrate at the follicular site, suggested that the depigmentation primarily affected hair follicle melanocytes. This finding aligned with previous reports on follicular vitiligo, a form of non-segmental vitiligo where hair follicle melanocytes are primarily and predominantly involved, contrasting with classical non-segmental vitiligo, which primarily affects epidermal melanocytes.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 13 results

      community One full year of treatment before and after

      in Progress Pictures  18 upvotes 4 months ago
      A user shared their one-year progress with hair loss treatment, using topical minoxidil, 2% keto shampoo, microneedling, and finasteride. They plan to start dutasteride and are considering switching to oral minoxidil.

      community When someone posts a scalp tension theory

      in Satire  265 upvotes 3 years ago
      Hair loss theories discussed include poor blood flow, scalp tension, inflammation, and DHT. Treatments mentioned are massaging scalp, minoxidil, finasteride, and RU58841.

      community 2 years progress (28M). Finally posting my results

      in Update  216 upvotes 3 months ago
      A 28-year-old shared his 2-year hair loss treatment progress using finasteride, minoxidil, dermarolling, and Revita shampoo. He saw significant improvement, especially with minoxidil and dermarolling, and stressed consistency.
      The story of RU58841/ PSK3841

      community The story of RU58841/ PSK3841

      in Research  622 upvotes 4 months ago
      RU58841, a potential hair loss treatment, was not commercialized due to marketability issues and lack of long-term safety data. Concerns about its formulation and delivery methods further complicate its use.

    Similar Research

    5 / 1000+ results